That the Senate—
expresses support for the designation of September 15, 2022, as “International Myotonic Dystrophy Awareness Day”;
recognizes the seriousness of myotonic dystrophy; and
supports the goals and ideals of International Myotonic Dystrophy Awareness Day, which include—
committing to promoting and advancing the health, well-being, and inherent dignity of all children and adults with myotonic dystrophy;
supporting the advancement of scientific and medical myotonic dystrophy research;
fostering biopharmaceutical innovation that will lead to Food and Drug Administration-approved treatments and eventually a cure for myotonic dystrophy;
advancing programs and policies that assist individuals living with myotonic dystrophy and the caregivers of such individuals; and
encouraging awareness and education of myotonic dystrophy for patients, caregivers, clinicians, and researchers.